Records containing: Relapsing Remitting Multiple Sclerosis

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2014-01-06
  A Multi-Centered, Randomized, Double-Blind, Placebo Controlled Study Assessing the Add-on Effect of Oral Steroids in Relapsing Remitting Multiple Sclerosis Subjects Treated With Glatiramer Acetate (GA)
• CLINICAL_TRIALS study record update · 2013-09-23
  A Phase 3, Multicenter, Double-blind,Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of NU100 in Patients With Relapsing Forms of Multiple Sclerosis
• CLINICAL_TRIALS study record update · 2013-04-04
  Pilot Study for Evaluation of Glatiramer Acetate in RRMS Patients With Comorbid Autoimmune Conditions
• CLINICAL_TRIALS study record update · 2013-01-30
  Randomized Treatment Interruption of Natalizumab
• CLINICAL_TRIALS study record update · 2012-10-12
  Impact of Vitamin A Supplementation on RAR Gene Expression in PBMC Cells in Multiple Sclerotic Patients
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2012-07-18
  The Impact of Vitamin A Supplementation on Gene Expression of Cytokine Secreted by CD4+ T Lymphocyte in Multiple Sclerosis Patients
• CLINICAL_TRIALS study record update · 2011-08-16
  Impact of Vitamin A Supplementation on Disease Activity and Progression in Multiple Sclerotic (MS) Patients
• CLINICAL_TRIALS study record update · 2011-06-09
  An Open-Label, Multicenter, Randomized Study Evaluating the Tolerability and Safety of Two Formulations of Glatiramer Acetate (GA) for Subcutaneous Injection
• CLINICAL_TRIALS study record update · 2011-04-14
  A Multi-Center, Randomized, Open Label Study To Evaluate Safety, Tolerability And Efficacy Of Treatment With Mitoxantrone; Pre-Treatment With Glatiramer Acetate (GA) Versus Treatment With GA Alone In Relapsing Forms Of Multiple Sclerosis.
• CLINICAL_TRIALS study record update · 2011-04-08
  A Multinational, Multicenter Randomized Double-Blind, Parallel-Group, Placebo-Controlled Study, to Evaluate the Efficacy, Tolerability and Safety of Two Doses of, Oral Laquinimod in Relapsing Remitting (R-R) Multiple Sclerosis (MS) Subjects
• CLINICAL_TRIALS study record update · 2010-10-18
  A Multi-Center, Randomized, Single-Blind, Parallel Group Study to Compare the Efficacy, Tolerability and Safety, of Copaxone® to That of High Dose Interferon (Betaseron® or Rebif®) in the Treatment of Relapsing Multiple Sclerosis Patients
• CLINICAL_TRIALS study record update · 2010-09-09
  A Double Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of MBP8298 in Relapsing Remitting Multiple Sclerosis
• CLINICAL_TRIALS study record update · 2010-08-27
  Multicentre, Single Arm, Open, Phase IV Study To Evaluate Immunogenicity And Safety Of Subcutaneous r-hIFN Beta-1a (Rebif®) Using Clone 484-39 In The Treatment Of Relapsing Remitting Multiple Sclerosis
• CLINICAL_TRIALS study record update · 2010-07-30
  ClinicalTrials.gov study NCT00668343
• CLINICAL_TRIALS study record update · 2010-05-14
  A Multinational, Multicenter, Randomized, Parallel-Group, Double-Blind Study to Compare the Efficacy, Tolerability and Safety of Glatiramer Acetate Injection 40 mg/ml to That of Glatiramer Acetate Injection 20 mg/ml Administered Once Daily by Subcutaneous Injection in Subjects With Relapsing Remitting (R-R) Multiple Sclerosis (MS)
• CLINICAL_TRIALS study record update · 2010-04-29
  A Multi-Centered, Two Arm, Open Label Extension Study (to Protocol NC-100) to Evaluate the Long-Term Safety and Efficacy of Short-Term Induction Treatment With Mitoxantrone (Novantrone®) Preceding Treatment With Glatiramer Acetate (Copaxone®) vs. Chronic Treatment With Glatiramer Acetate Alone in Relapsing Forms of Multiple Sclerosis
• CLINICAL_TRIALS study record update · 2009-06-05
  Comparison of Alemtuzumab (Campath®) and High Dose Interferon Beta-1a (Rebif®) Treatment on Cognition in Subjects With Relapsing Forms of MS
• CLINICAL_TRIALS study record update · 2009-01-05
  Eszopiclone for Improving Sleep Continuity in MS Patients With Sleep Disturbances and Its Impact on Daytime Fatigue
• CLINICAL_TRIALS study record update · 2008-09-04
  An Open-Label Study to Examine the Difference in Tolerability Associated With Titration Of Dose on Initiation of Avonex therapY (TODAY)
• CLINICAL_TRIALS study record update · 2008-02-11
  BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis
• CLINICAL_TRIALS study record update · 2007-12-13
  Evaluation of the Correlation Between the MS Functional Composite Index and Two Quality of Life Scales (MS54 and AMS Quality of Life) in Relapsing MS Patients Treated With Interferon Beta-1a (AVONEX®)
• CLINICAL_TRIALS study record update · 2007-01-05
  Clinical Study Protocol: Evaluation of the Efficiency of Ritalin in Multiple Sclerosis Patients